Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP

被引:99
|
作者
Hetherington, SL [1 ]
Singh, RK [1 ]
Lodwick, D [1 ]
Thompson, JR [1 ]
Goodall, AH [1 ]
Samani, NJ [1 ]
机构
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England
关键词
platelets; thrombosis; genes; receptors; adenosine diphosphate;
D O I
10.1161/01.ATV.0000148708.44691.27
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - The platelet ADP receptors P2Y1 and P2Y12 play a pivotal role in platelet aggregation. There is marked interindividual variation in platelet response to ADP. We studied whether genetic variants in the P2Y1 or P2Y12 genes affect platelet response to ADP. Methods and Results - The P2Y1 and P2Y12 genes were screened for polymorphisms. Associations between selected polymorphisms and the platelet response to ADP (0.1, 1.0, and 10 mumol/L), assessed by whole blood flow cytometric measurement of fibrinogen binding to activated glycoprotein IIb-IIIa, were then determined in 200 subjects. Five polymorphisms were found in the P2Y1 gene and 11 in the P2Y12 gene. All polymorphisms were silent. A P2Y1 gene dimorphism, 1622A>G, was associated with a significant (P=0.007) effect on platelet ADP response, with a greater response in carriers of the G allele (frequency 0.15). The effect was seen at all concentrations of ADP but greatest at 0.1 mumol/L ADP, where the response in GG homozygotes was on average 130% higher than that seen in AA homozygotes (P=0.006). Conclusions - A common genetic variant at the P2Y1 locus is associated with platelet reactivity to ADP. This genotype effect partly explains the interindividual variation in platelet response to ADP and may have clinical implications with regard to thrombotic risk.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 50 条
  • [31] Patients with congenital abnormality of platelet aggregation induced by Ca2+ ionophores may have a defect of the platelet P2Y12 receptor for ADP
    Cattaneo, M
    Lecchi, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) : 485 - 486
  • [32] Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y12 Antagonist
    Iyu, David
    Glenn, Jackie R.
    White, Ann E.
    Fox, Sue C.
    Heptinstall, Stan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (02) : 416 - 422
  • [33] Benzofuran-substituted urea derivatives as novel P2Y1 receptor antagonists
    Thalji, Reema K.
    Aiyar, Nambi
    Davenport, Elizabeth A.
    Erhardt, Joseph A.
    Kallal, Lorena A.
    Morrow, Dwight M.
    Senadhi, Shobha
    Burns-Kurtis, Cynthia L.
    Marino, Joseph P., Jr.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (14) : 4104 - 4107
  • [34] New azole antagonists with high affinity for the P2Y1 receptor
    Ruel, Rejean
    L'Heureux, Alexandre
    Thibeault, Carl
    Daris, Jean-Paul
    Martel, Alain
    Price, Laura A.
    Wu, Qimin
    Hua, Ji
    Wexler, Ruth R.
    Rehfuss, Robert
    Lam, Patrick Y. S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (12) : 3519 - 3522
  • [35] QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y12) antagonist
    Al-Najjar, Belal O. O.
    Abbas, Manal A. A.
    Sibai, Obada A. A.
    Saqallah, Fadi G. G.
    Al-Kabariti, Aya Y. Y.
    RSC MEDICINAL CHEMISTRY, 2023, 14 (02): : 239 - 246
  • [36] ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice
    Amisten, S.
    Meidute-Abaraviciene, S.
    Tan, C.
    Olde, B.
    Lundquist, I.
    Salehi, A.
    Erlinge, D.
    DIABETOLOGIA, 2010, 53 (09) : 1927 - 1934
  • [37] New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors
    Yanachkov, Ivan B.
    Chang, Hung
    Yanachkova, Milka I.
    Dix, Edward J.
    Berny-Lang, Michelle A.
    Gremmel, Thomas
    Michelson, Alan D.
    Wright, George E.
    Frelinger, Andrew L., III
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 107 : 204 - 218
  • [38] Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane
    Rabani, Vahideh
    Montange, Damien
    Meneveau, Nicolas
    Davani, Siamak
    PLATELETS, 2018, 29 (07) : 709 - 715
  • [39] Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist
    Lenain, N
    Freund, M
    Léon, C
    Cazenave, JP
    Gachet, C
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (06) : 1144 - 1149
  • [40] Low-intensity pulsed ultrasound-dependent osteoblast proliferation occurs by via activation of the P2Y receptor: Role of the P2Y1 receptor
    Alvarenga, Erika Costa
    Rodrigues, Renata
    Caricati-Neto, Afonso
    Silva-Filho, Fernando Costa
    Paredes-Gamero, Edgar J.
    Ferreira, Alice T.
    BONE, 2010, 46 (02) : 355 - 362